Prokidney (PROK) Change in Interest Receivables (2023 - 2026)
Prokidney's (PROK) quarterly Change in Interest Receivables came in at -$76000.0 in Q2 2026, down 430.43% year-over-year from $23000.0 in Q2 2025, and up 20.0% quarter-over-quarter from -$95000.0 in Q1 2026.
Powered by 
Analysis
Prokidney (PROK) Change in Interest Receivables (2023 - 2026) Analysis & Trends
Prokidney (PROK) has reported Change in Interest Receivables for 4 consecutive years, with -$76000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Interest Receivables fell 430.43% year-over-year to -$76000.0 in Q2 2026; TTM through Jun 2026 was -$819000.0, a 15.83% increase from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 223.13% from the prior year.
- Change in Interest Receivables was -$76000.0 for Q2 2026 at Prokidney, up from -$95000.0 in the prior quarter.
- Over five years, Change in Interest Receivables peaked at $5.5 million in Q1 2023 and troughed at -$7.4 million in Q3 2023.
- A 4-year average of $68285.7 and a median of -$26500.0 in 2025 frame the typical range for Change in Interest Receivables.
- The widest YoY moves for Change in Interest Receivables: up 131.93% in 2024, down 501.82% in 2024.
- Over 4 years, Change in Interest Receivables stood at $661000.0 in 2023, then tumbled by 501.82% to -$2.7 million in 2024, then surged by 95.86% to -$110000.0 in 2025, then surged by 30.91% to -$76000.0 in 2026.
- The last three Change in Interest Receivables figures came in at -$76000.0 (Q2 2026), -$95000.0 (Q1 2026), and -$110000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -76,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -76,000.00 |
| Mar 31, 2026 | -95,000.00 |
| Dec 31, 2025 | -110,000.00 |
| Sep 30, 2025 | -538,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | -695,000.00 |
| Dec 31, 2024 | -2.66 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 844,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 661,000.00 |
| Sep 30, 2023 | -7.38 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 5.48 Mn |